Cost Effectiveness of Risk-Based Lung Cancer Screening
According to a recent study that was published in the Annals of Internal Medicine, a risk-based lung cancer screening program was more cost-effective than the updated United States Preventive Services Task Force (USPSTF) recommendations. Implementing models of individualized lung cancer risk should be considered for future USPSTF recommendations. Learn more about the results of this study.
Targeted Therapies Underused in Medicaid Programs
Findings from a recent study published in the Journal of the American Medical Association reveal that targeted therapies for treating patients with epidermal growth factor receptor mutations and anaplastic large-cell lymphoma kinase altered, metastatic non-small cell lung cancer are often underutilized in many state Medicaid programs. This restricts access to efficacious treatments. Learn more about the results of this study.